In vivo quantification of choline compounds in the breast with 1H MR spectroscopy.
about
The potential of terahertz imaging for cancer diagnosis: A review of investigations to dateImaging in breast cancer: Magnetic resonance spectroscopyMolecular magnetic resonance imaging in cancerIdentification of Gastric Cancer Biomarkers Using 1H Nuclear Magnetic Resonance Spectrometry3.0 T proton magnetic resonance spectroscopy of the liver: quantification of cholineSilencing of the glycerophosphocholine phosphodiesterase GDPD5 alters the phospholipid metabolite profile in a breast cancer model in vivo as monitored by (31) P MRS.Dixon imaging-based partial volume correction improves quantification of choline detected by breast 3D-MRSI.Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy.Quantitative correlation between (1)H MRS and dynamic contrast-enhanced MRI of human breast cancer.Scanning time-domain optical mammography: detection and characterization of breast tumors in vivo.Feasibility of single-voxel MRS measurement of apparent diffusion coefficient of water in breast tumors.Quantification of muscle choline concentrations by proton MR spectroscopy at 3 T: technical feasibility.Characterization of metabolic differences between benign and malignant tumors: high-spectral-resolution diffuse optical spectroscopy.Biochemical characterization of breast tumors by in vivo and in vitro magnetic resonance spectroscopy (MRS)A feasibility study of quantitative molecular characterization of musculoskeletal lesions by proton MR spectroscopy at 3 T.Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profilesDiagnostic usefulness of water-to-fat ratio and choline concentration in malignant and benign breast lesions and normal breast parenchyma: an in vivo (1) H MRS study.Magnetic resonance in the detection of breast cancers of different histological types.Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancerMRI in breast cancer therapy monitoringQuadrature transmit coil for breast imaging at 7 tesla using forced current excitation for improved homogeneityIn vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response.Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway.The added value of quantitative multi-voxel MR spectroscopy in breast magnetic resonance imaging.Physics of MRI: a primer.HR-MAS MR spectroscopy of breast cancer tissue obtained with core needle biopsy: correlation with prognostic factors.In vivo (1) H MR spectroscopic imaging of aggressive prostate cancer: can we detect lactate?Clinical characteristics and biomarkers of breast cancer associated with choline concentration measured by 1H MRS.Early response of hepatic malignancies to locoregional therapy-value of diffusion-weighted magnetic resonance imaging and proton magnetic resonance spectroscopyMagic angle spinning NMR-based metabolic profiling of head and neck squamous cell carcinoma tissuesDiscrimination of Basal Cell Carcinoma from Normal Skin Tissue Using High-Resolution Magic Angle Spinning 1H NMR SpectroscopyNMR metabolomics of MTLn3E breast cancer cells identifies a role for CXCR4 in lipid and choline regulation.Multiparametric magnetic resonance imaging, spectroscopy and multinuclear (²³Na) imaging monitoring of preoperative chemotherapy for locally advanced breast cancerMagnetic resonance in surgical oncology: II - literature review.Localized hypoxia results in spatially heterogeneous metabolic signatures in breast tumor models.In vivo proton magnetic resonance spectroscopy of breast cancer: a review of the literatureQuantitative mapping of total choline in healthy human breast using proton echo planar spectroscopic imaging (PEPSI) at 3 TeslaPattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics.Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism.Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience.
P2860
Q24613696-889008F4-28F8-4B47-8E5B-3AF0AB6E5518Q24810795-5DA2BEE5-A303-45E4-97A8-17707858EB7EQ26782151-69E1D144-7E52-4B24-9D68-89A0352945DCQ28553966-229DB210-9D27-4CEA-B45D-E14FD7E5A31CQ30608766-8C3B9164-D66C-45B9-85D8-DE1F9C14D0D4Q30808489-0D0A3AC3-38B4-42A3-BDEB-A42D96894B4DQ30851059-CFACCBD7-DA1E-492A-B4EC-3CD64E17BEC9Q31032006-DB06D49E-7EC2-4353-86AA-64991F3CC358Q31138977-DA7A7827-E9A7-44DC-A9FF-62EE8221F765Q33223641-777C556A-6CFB-4A9D-9C56-CE9D4DB96742Q33411449-C7DEDB94-D584-4D6E-AAD9-C9DF2AFAFD42Q33520399-C29728A8-6D88-47F7-BC86-5675B68DA1D0Q33520641-525AD7B6-E1D8-416E-B9E6-4C1A7C0BE863Q33552272-F772D3B1-9472-40AE-BBEF-216799B3EFEDQ33611764-D7B0FF10-0785-4BBA-9D6A-BAD0CBF47462Q33639706-1464F167-1A15-4793-8B12-13A123300AA6Q33857530-0B4B5D68-498F-4A86-B3A6-3799F38B4DEAQ33873362-6B8BD96D-6126-46DD-8FC3-E4DDC97FC027Q33881902-FDFA333C-F542-45F6-A6A2-73C67116898BQ33938324-99C9468C-EAA2-49A6-9CFC-C0EF713B9248Q33946726-AFA30841-579A-43D5-A12E-843C0A5232D5Q34016780-16389087-3A70-4B74-AF6A-B9CC1F286622Q34035237-B990D500-EE50-4086-A809-1143656A116DQ34072785-6AE65C56-2833-4121-9976-5C59187ADA8AQ34231471-1395614F-E900-44AF-A260-8325FDE21F94Q34525558-66070C30-FC8C-4201-9807-1E98D396D028Q34615828-536A3A3A-19BB-4448-B842-AF4C1126F1DCQ34788629-BC2B706B-F60E-426C-9234-66DCE950538EQ35095985-66613ED9-0DD4-4ACA-A901-E2E1B1886C8EQ35529046-1D707766-8B55-417A-AFF1-E7EBBE20D8E7Q35943239-333E531D-4D45-4125-81F9-80418372B792Q36043738-F3981AF6-E108-4E72-BF2A-7850C62C31ECQ36106087-D6D6726E-98EE-4DBB-9549-4BA85A3C6C61Q36155915-328BD9B1-3373-4C64-BC47-AE55C9D70E8DQ36200422-4A91F2B7-CF19-4A0F-B5FB-31E1ADC46D37Q36245493-E9E8AC7E-E77C-4BFA-9C07-BD7720B42E00Q36315433-17C54BDD-90C9-47D2-9407-3632ED06BB96Q36607286-7D9BF493-CB79-4578-8951-0729FC64328EQ36630017-B01EA30B-EFD9-450C-868C-A59577E1EA62Q36638498-C28DE483-F3BE-45AE-93B3-010715D17ADC
P2860
In vivo quantification of choline compounds in the breast with 1H MR spectroscopy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
In vivo quantification of choline compounds in the breast with 1H MR spectroscopy.
@ast
In vivo quantification of choline compounds in the breast with 1H MR spectroscopy.
@en
type
label
In vivo quantification of choline compounds in the breast with 1H MR spectroscopy.
@ast
In vivo quantification of choline compounds in the breast with 1H MR spectroscopy.
@en
prefLabel
In vivo quantification of choline compounds in the breast with 1H MR spectroscopy.
@ast
In vivo quantification of choline compounds in the breast with 1H MR spectroscopy.
@en
P2093
P356
P1476
In vivo quantification of choline compounds in the breast with 1H MR spectroscopy
@en
P2093
Eva H Baker
Joseph Lin
Lenore I Everson
Michael Garwood
Michael Nelson
Patrick J Bolan
Sina Meisamy
Timothy Emory
P304
P356
10.1002/MRM.10654
P50
P577
2003-12-01T00:00:00Z